Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by RANDAL S WEBER and JEFFREY N MYERS.
RANDAL S WEBER
Connection Strength
1.144
JEFFREY N MYERS
  1. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head Neck. 2011 Feb; 33(2):189-98.
    View in: PubMed
    Score: 0.100
  2. Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples. Am J Pathol. 2011 Feb; 178(2):548-71.
    View in: PubMed
    Score: 0.100
  3. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol. 2023 Apr; 30(4):2331-2338.
    View in: PubMed
    Score: 0.057
  4. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol. 2022 11; 134:106127.
    View in: PubMed
    Score: 0.056
  5. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surg Oncol. 2022 Sep; 44:101804.
    View in: PubMed
    Score: 0.055
  6. Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2022 Apr 14; 28(8):1735.
    View in: PubMed
    Score: 0.054
  7. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer. 2021 12 01; 127(23):4413-4420.
    View in: PubMed
    Score: 0.052
  8. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2021 08 15; 27(16):4557-4565.
    View in: PubMed
    Score: 0.051
  9. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. Head Neck. 2021 05; 43(5):1592-1603.
    View in: PubMed
    Score: 0.050
  10. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer. 2021 02; 144:169-177.
    View in: PubMed
    Score: 0.050
  11. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer. 2021 04 15; 127(8):1238-1245.
    View in: PubMed
    Score: 0.050
  12. Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center. Cancer. 2020 11 15; 126(22):4905-4916.
    View in: PubMed
    Score: 0.049
  13. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.048
  14. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2020 02 01; 146(2):128-135.
    View in: PubMed
    Score: 0.047
  15. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis. Ann Diagn Pathol. 2019 Aug; 41:14-23.
    View in: PubMed
    Score: 0.044
  16. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
    View in: PubMed
    Score: 0.032
  17. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e367-74.
    View in: PubMed
    Score: 0.027
  18. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2011 Nov; 32(11):1668-74.
    View in: PubMed
    Score: 0.026
  19. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.023
  20. Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024. J Clin Oncol. 2009 Oct 01; 27(28):4727-32.
    View in: PubMed
    Score: 0.023
  21. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 01; 112(9):2088-100.
    View in: PubMed
    Score: 0.021
  22. Recent advances in thyroid cancer. In brief. Curr Probl Surg. 2008 Mar; 45(3):149-51.
    View in: PubMed
    Score: 0.020
  23. Recent advances in thyroid cancer. Curr Probl Surg. 2008 Mar; 45(3):156-250.
    View in: PubMed
    Score: 0.020
  24. The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium. Int J Radiat Oncol Biol Phys. 2007; 69(2 Suppl):S1-3.
    View in: PubMed
    Score: 0.019
  25. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res. 2006 Dec 15; 12(24):7353-8.
    View in: PubMed
    Score: 0.019
  26. Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005 Aug; 27(8):718-21.
    View in: PubMed
    Score: 0.017
  27. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol. 2005 Jul; 36(7):821-7.
    View in: PubMed
    Score: 0.017
  28. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion! Oral Oncol. 2005 Jul; 41(6):580-8.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.